Financial Operations Insights, Guides, and Tools
R&D Credit Documentation Is Getting Stricter: What Form 6765 Changes Mean for 2026
The R&D credit is a critical benefit for life sciences companies and other research-focused organizations. With the ability to cover up to 25% of qualified costs, the credit can significantly ease the tax burden, fuel innovation, and improve cash flow, even for pre-revenue companies.
CFO Advisory for Life Sciences: Tracking KPIs That Actually Matter
Success in life sciences is as much about financial planning and timing as it is about the mission itself. Research and development (R&D), clinical trials, and regulatory approvals are resource-heavy and typically funded through investment, requiring meticulous financial management, reporting, and planning to ensure plans stay on track.
Life Sciences Financial Statements: What Investors Expect (and What CPAs Fix)
Financial reporting is an essential accounting practice for all businesses. Factual financial reports inform planning and critical business decisions and are required for stakeholder edification, especially in life sciences, which relies heavily on funding from investors and grant organizations.
R&D Tax Credit for Biotech and Life Sciences Companies: Eligibility, Documentation, and Examples
Biotech and life sciences firms invest significant resources in research and development. Fortunately, the government recognizes the value of this effort and offers tax credits to offset these costs, which can be a massive support for pre-revenue or unprofitable startups.
Life Sciences Tax Planning: A CPA Guide for Biotech, MedTech, and Pharma
The life sciences, biotech, MedTech, and pharmaceutical industries are among the most highly regulated industries. Companies in this niche contend with heavy compliance burdens, rapid-fire regulatory changes, and must always be ready for an audit or enforcement, often without advance notice.
Internal Controls for Life Sciences Startups: The “Pre-Audit” Checklist
Life sciences startups are typically not laser-focused on anything beyond innovation and their current projects, and finding the funding they need to keep it all going. However, without proper internal controls and SOPs, compliance and regulatory approvals may be challenging.
Clinical Trial Accruals: How Finance Teams Avoid Quarter-End Surprises
Clinical trials are complex endeavors, often spanning years and rarely aligning with a company’s accounting periods. And therein lies the challenge: how do finance teams accurately track trial accrual and avoid nasty surprises when closing out the quarter? When the numbers don’t line up, there is a distinct ripple effect in financial statements, and investors and decision-makers will undoubtedly feel the consequences.